Skip to main content

Misinterpretation of Coronary Cholesterol Atheromata in Cholesterol-Fed Rabbits as Suitable Model for Conventional Human Coronary Plaques

  • Chapter
Oxygen Transport to Tissue XVI

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 361))

  • 25 Accesses

Abstract

Occlusion of coronary arteries following arteriosclerotic plaque formation with thrombotic complications is the main etiological factor in the development of myocardial ischemia with subsequent infarction and cell necrosis. Originally, in the 16th century, arteriosclerosis was considered to be an “ossification” of arteries1. Hodgson2 was the first to report in 1815 chemical analyses of arterial plaques, which contained 65% calcium (Ca) salts and 35% organic matter. However, current concepts of the development of arteriosclerosis are overshadowed by the assumption, that the main etiological factor is an enormous accumulation of lipids, particularly cholesterol, in the arterial walls brought about by an increase in serum cholesterol3. Consequently, arterial cholesterol atheromata of cholesterol-fed rabbits are widely considered to be suitable experimental models for conventional human arteriosclerosis4. Moreover, standard anti-arteriosclerotic therapy particularly aims at the so-called “normalization” of serum lipids. Our present data, obtained from microchemical analyses of coronary artery plaques of cholesterol-fed rabbits, and humans respectively, enhance the doubts about an exclusive cholesterol hypothesis of conventional atherogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. E.R. Long, Development of our knowledge of arteriosclerosis,in: “Cowdy’s arteriosclerosis. A survey of the problem,” H.T. Blumenthal, ed., First Edition., Charles C Thomas, Springfield/Ill USA (1933).

    Google Scholar 

  2. J. Hodgson. “Treatise on the diseases of arteries and veins,” (1815).

    Google Scholar 

  3. M.S. Brown, and J.L. Goldstein, How LDL receptors influence cholesterol and atherosclerosis. Sci Am. 251(5):58 (1984).

    Article  PubMed  CAS  Google Scholar 

  4. N. Anitschkow, and S. Chalatow, Über experimentelle Cholesterinsteatose and ihre Bedeutung für die Entstehung einiger pathologischer Prozesse. Zentralbi. Allgemeine Pathol u Anat. 14:1 (1913).

    Google Scholar 

  5. G. Fleckenstein-Grün, M. Frey, F. Thimm, C. Luley, A. Czirfusz, and A. Fleckenstein, Differentiation between calcium-and cholesterol-dominated types of arteriosclerotic lesions: Antiarteriosclerotic aspects of calcium antagonists. J Cardiovasc Phan-naco1.18(Suppl 6): S1 (1991).

    Google Scholar 

  6. A. Fleckenstein, M. Frey, F. Thimm, and G. Fleckenstein-Grün, Excessive mural calcium overload - A predominant causal factor in the development of stenosing coronary plaques in humans. Cardiovasc Drugs and Therapy. 4:1005 (1990).

    Article  Google Scholar 

  7. G. Fleckenstein-Grün, and A. Fleckenstein, Calcium - A neglected key factor in arteriosclerosis. The pathogenetic role of arterial calcium overload and its prevention by calcium antagonists, Ann Med. 23:589 (1991).

    Article  PubMed  Google Scholar 

  8. G. Fleckenstein-Grün, F. Thimm, M. Frey, and A. Czirfusz. Role of calcium in arteriosclerosis. Experimental evaluation of antiarteriosclerotic potencies of Ca antagonists, Basic Res Cardiol, accepted, in press (1993).

    Google Scholar 

  9. A. Fleckenstein, M. Frey, J. Zorn, and G. Fleckenstein-Grün, Calcium, a neglected key factor in hypertension and arteriosclerosis. Experimental vasoprotection with calcium antagonists or ACE inhibitors, in: “Hypertension: Pathophysiology, Diagnosis, and Mannagement.” J.H. Laragh and B.M. Brenner eds.,Raven Press, New York, 471 (1990).

    Google Scholar 

  10. G. Fleckenstein-Grün, M. Frey, F. Thimm, and A. Fleckenstein, Protective effects of various calcium antagonists against experimental arteriosclerosis, J Human Hypertension 6 (Suppl 1): S13

    Google Scholar 

  11. G. Fleckenstein-Grün, F. Thimm, A. Czirfusz, S. Matyas, and M. Frey, Experimental vasoprotection by calcium antagonists against Ca-mediated arteriosclerotic alterations. J Cardiovasc Pharmacol, accepted, in press (1993).

    Google Scholar 

  12. P.R. Lichtlen, P.G. Hugenholtz, W. Rafflenbeul, H. Hecker, S. Jost, P. Nikutta, J.W. Deckers, Retardation of coronary artery disease in in humans by the calcium channel blocker nifedipine: Results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy). Cardiouasc Drugs and Therapy. 4: 1047 (1990).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Thimm, F., Frey, M., Fleckenstein-Grün, G. (1994). Misinterpretation of Coronary Cholesterol Atheromata in Cholesterol-Fed Rabbits as Suitable Model for Conventional Human Coronary Plaques. In: Hogan, M.C., Mathieu-Costello, O., Poole, D.C., Wagner, P.D. (eds) Oxygen Transport to Tissue XVI. Advances in Experimental Medicine and Biology, vol 361. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1875-4_74

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-1875-4_74

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5763-6

  • Online ISBN: 978-1-4615-1875-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics